BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol. 2014;29:1356-1360. [PMID: 24548074 DOI: 10.1111/jgh.12560] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Le BH, Aggarwal G, Douglas C, Green M, Nicoll A, Ahmedzai S. Oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe, chronic cancer pain: Challenges in the context of hepatic impairment. Asia Pac J Clin Oncol 2021. [PMID: 33660420 DOI: 10.1111/ajco.13561] [Reference Citation Analysis]
2 Starczewska MH, Mon W, Shirley P. Anaesthesia in patients with liver disease. Current Opinion in Anaesthesiology 2017;30:392-8. [DOI: 10.1097/aco.0000000000000470] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
3 Bluth MH, Pincus MR. Narcotic Analgesics and Common Drugs of Abuse. Clinics in Laboratory Medicine 2016;36:603-34. [DOI: 10.1016/j.cll.2016.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Facciorusso A, Amoruso A, Neve V, Antonino M, Prete VD, Barone M. Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis. World J Hepatol 2014; 6(11): 793-799 [PMID: 25429317 DOI: 10.4254/wjh.v6.i11.793] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
5 Klinge M, Coppler T, Liebschutz JM, Dugum M, Wassan A, DiMartini A, Rogal S. The assessment and management of pain in cirrhosis. Curr Hepatol Rep 2018;17:42-51. [PMID: 29552453 DOI: 10.1007/s11901-018-0389-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Pathania S, Slater LZ, Vose C, Navarra AM. Music Therapy and Pain Management in Patients with End-Stage Liver Disease: An Evidence-Based Practice Quality Improvement Project. Pain Manag Nurs 2019;20:10-6. [PMID: 30448441 DOI: 10.1016/j.pmn.2018.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wong M, Busuttil RW. Surgery in Patients with Portal Hypertension. Clin Liver Dis. 2019;23:755-780. [PMID: 31563221 DOI: 10.1016/j.cld.2019.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Moon AM, Watkins SE, Lok AS, Firpi-Morell RJ, Trinh HN, Kupec JT, Schoen C, Neuschwander-Tetri BA, Barritt AS. Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. Dig Dis 2021;39:247-57. [PMID: 32836224 DOI: 10.1159/000511074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Rogal SS, Chinman MJ, DeMonte W, Gibson S, Hoyt-Trapp S, Klima GJ, Jonassaint NL, Liebschutz JM, Kraemer KL, Merlin J. Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis. Dig Dis Sci 2022. [PMID: 35147816 DOI: 10.1007/s10620-022-07380-4] [Reference Citation Analysis]
10 Nojkov B, Cappell MS. Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis. World J Gastroenterol 2016; 22(1): 446-466 [PMID: 26755890 DOI: 10.3748/wjg.v22.i1.446] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
11 Rogal SS, Bielefeldt K, Wasan AD, Szigethy E, Lotrich F, DiMartini AF. Fibromyalgia symptoms and cirrhosis. Dig Dis Sci 2015;60:1482-9. [PMID: 25433921 DOI: 10.1007/s10620-014-3453-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kress HG, Untersteiner G. Clinical update on benefit versus risks of oral paracetamol alone or with codeine: still a good option? Current Medical Research and Opinion 2017;33:289-304. [DOI: 10.1080/03007995.2016.1254606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Gallagher J, Biesboer AN, Killian AJ. Pharmacologic Issues in Liver Disease. Critical Care Clinics 2016;32:397-410. [DOI: 10.1016/j.ccc.2016.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Rodríguez Martínez S, Talaván Serna J, Silvestre FJ. [Dental management in patients with cirrhosis]. Gastroenterol Hepatol 2016;39:224-32. [PMID: 26541210 DOI: 10.1016/j.gastrohep.2015.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Casler K, Chaney A. Cirrhosis: An evidence-based approach. Nursing 2021;51:24-34. [PMID: 33953095 DOI: 10.1097/01.NURSE.0000731828.24893.bb] [Reference Citation Analysis]
16 Diaz KE, Schiano TD. Evaluation and Management of Cirrhotic Patients Undergoing Elective Surgery. Curr Gastroenterol Rep 2019;21:32. [PMID: 31203525 DOI: 10.1007/s11894-019-0700-y] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Zgheib NK, Branch RA. Drug metabolism and liver disease: a drug-gene-environment interaction. Drug Metab Rev 2017;49:35-55. [PMID: 27957864 DOI: 10.1080/03602532.2016.1271807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
18 Moyano J, Aguirre L. Opioids in the immune system: from experimental studies to clinical practice. Rev Assoc Med Bras (1992). 2019;65:262-269. [PMID: 30892453 DOI: 10.1590/1806-9282.65.2.262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
19 Alchin J, Dhar A, Siddiqui K, Christo PJ. Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older. Curr Med Res Opin 2022;:1-36. [PMID: 35253560 DOI: 10.1080/03007995.2022.2049551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tovoli F, De Lorenzo S, Samolsky Dekel BG, Piscaglia F, Benevento F, Brandi G, Bolondi L. Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma. Liver Int 2018;38:278-84. [PMID: 28792650 DOI: 10.1111/liv.13546] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
21 McGill MR, James LP, McCullough SS, Moran JH, Mathews SE, Peterson EC, Fleming DP, Tripod ME, Vazquez JH, Kennon-McGill S, Spencer HJ, Dranoff JA. Short-Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis. Hepatol Commun 2021. [PMID: 34558847 DOI: 10.1002/hep4.1810] [Reference Citation Analysis]
22 Premkumar M, Anand AC. Overview of Complications in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.021] [Reference Citation Analysis]
23 Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM. Opioid Drugs in Patients With Liver Disease: A Systematic Review. Hepat Mon 2016;16:e32636. [PMID: 27257423 DOI: 10.5812/hepatmon.32636] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
24 Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, Chinman M, Morgan T, Gellad WF. Characteristics of Opioid Prescriptions to Veterans With Cirrhosis. Clin Gastroenterol Hepatol 2019;17:1165-1174.e3. [PMID: 30342261 DOI: 10.1016/j.cgh.2018.10.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
25 Rogal SS, Hansen L, Patel A, Ufere NN, Verma M, Woodrell CD, Kanwal F. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022. [PMID: 35103995 DOI: 10.1002/hep.32378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Agbalajobi OM, Gmelin T, Moon AM, Alexandre W, Zhang G, Gellad WF, Jonassaint N, Rogal SS. Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action. PLoS One 2021;16:e0261377. [PMID: 34919585 DOI: 10.1371/journal.pone.0261377] [Reference Citation Analysis]
27 Edelson JC, Rockey DC. Endoscopic Sedation of the Patient With Cirrhosis. Clin Liver Dis (Hoboken). 2018;12:165-169. [PMID: 30988936 DOI: 10.1002/cld.762] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Bittencourt PL, Terra C, Parise ER, Farias AQ, Arroyo V, Fernandez J, Pereira G, Maubouisson LM, Andrade GM, Costa FG, Codes L, Andrade AR, Mattos AA, Torres A, Couto F, Zyngier I. Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology. Arq Gastroenterol 2015;52 Suppl 1:55-72. [PMID: 26959806 DOI: 10.1590/S0004-28032015000500004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
29 Bloom A, Mudiyansalage VW, Rhodes A, Hogg M, Jayasekera C, Gorelik A, Sood S, Nicoll A. Can adequate analgesia be achieved in patients with cirrhosis without precipitating hepatic encephalopathy? A prospective study. Clin Exp Hepatol 2020;6:243-52. [PMID: 33145431 DOI: 10.5114/ceh.2020.99521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol. 2016;81:210-222. [PMID: 26460177 DOI: 10.1111/bcp.12802] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
31 Maljean L, Gavazzi G, Gibert P, Grevy A, Payen M, Zerhouni N, Tiffet T, Cracowski J, Mitha N, Maindet C, Baudrant M, Bedouch P, Drevet S. Tolerance of Fentanyl Pectin Nasal Spray for Procedural Pain in Geriatric Patients. Journal of the American Medical Directors Association 2022. [DOI: 10.1016/j.jamda.2022.03.005] [Reference Citation Analysis]
32 Darr U, Sussman NL. Drug-Induced Liver Injury in the Setting of Analgesic Use. Clin Liver Dis. 2020;24:121-129. [PMID: 31753245 DOI: 10.1016/j.cld.2019.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
33 Hyland SJ, Brockhaus KK, Vincent WR, Spence NZ, Lucki MM, Howkins MJ, Cleary RK. Perioperative Pain Management and Opioid Stewardship: A Practical Guide. Healthcare (Basel) 2021;9:333. [PMID: 33809571 DOI: 10.3390/healthcare9030333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Hong YM, Yoon KT, Heo J, Woo HY, Lim W, An DS, Han JH, Cho M. The Prescription Pattern of Acetaminophen and Non-Steroidal Anti-Inflammatory Drugs in Patients with Liver Cirrhosis. J Korean Med Sci 2016;31:1604-10. [PMID: 27550489 DOI: 10.3346/jkms.2016.31.10.1604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
35 Crighton AJ, McCann CT, Todd EJ, Brown AJ. Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic. Br Dent J 2020;229:15-8. [PMID: 32651512 DOI: 10.1038/s41415-020-1784-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Khalifa C, Boliaki Botombe G, Stephenne X, Veyckemans F. Anesthetic Care of 2 Siblings With Neonatal Ichthyosis and Sclerosing Cholangitis Syndrome: Case Reports. A A Pract 2018;11:216-8. [PMID: 29738332 DOI: 10.1213/XAA.0000000000000785] [Reference Citation Analysis]